sufotidine usan codenamed longacting competitive receptor antagonist development antiulcerant glaxo planned followup compound ranitidine taken doses mg twice daily induced virtually gastric thus closely resembling antisecretory effect proton pump inhibitor development terminated phase iii clinical trials based appearance carcinoid tumors longterm toxicity testing httpsenwikipediaorgwikisufotidine